Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Achieve Life Sciences Inc ACHV

Healthcare Biotechnology
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with... see more

Current News (NDAQ:ACHV)

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

GlobeNewswire 9 days ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

GlobeNewswire January 30, 2026

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

GlobeNewswire January 12, 2026

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

GlobeNewswire December 8, 2025

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

GlobeNewswire November 6, 2025

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

GlobeNewswire November 3, 2025

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

GlobeNewswire October 29, 2025

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

GlobeNewswire October 20, 2025

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

GlobeNewswire October 17, 2025
View More News ››

Opinion & Analysis (NDAQ:ACHV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ACHV)

Using technical analysis for this stock.

It is showing a continuing uptrend for shareholders today,so good luck to all of you guys
coolfooldumbguy - October 17, 2025

Using technical analysis for this stock.

This stock is signalling strength to the upside for shareholders today so good luck to all
coolfooldumbguy - August 25, 2025

new site with deep DD on ACHV 👇

New site with Deep DD on ACHV: FrugalNorwegian.com - All information on 1 page - Catalyst countdown timer - Several videos to watch...
FrugalNorwegian - May 7, 2021

it's a sell today for me

will use this one for tax loss selling,this one didn't work out for me,so glta.
coolfooldumbguy - December 19, 2019

it's a buy today for me

at $1.15 per share,breaking out this morning,so glta.
coolfooldumbguy - December 17, 2019

Achieve Life Sciences

Just wondering if ACHV could go to $5 next week?
rubadub - February 22, 2019
View more Bullboard ››

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »

Podcasts